Gerresheimer Aktie 3138496 / DE000A0LD6E6
Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
---|---|---|---|---|---|---|
Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
Orderbuch | Analysen | |||||
Historisch |
04.08.2025 18:40:03
|
EQS-News: Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
EQS-News: Gerresheimer AG
/ Key word(s): Strategic Company Decision
Gerresheimer to Separate Moulded Glass and Intends to Initiate a Subsequent Sales Process
Duesseldorf, August 4, 2025. Following a comprehensive strategic review of its Moulded Glass business, Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, has decided to separate the business and intends to subsequently initiate a sales process for the business unit. The aim of the strategic review was to evaluate various options for the best growth prospects and competitiveness of the Moulded Glass business. The company now sees these outside the Gerresheimer Group. With the acquisition of Bormioli Pharma, Gerresheimer has formed a Moulded Glass Powerhouse with eight production plants across Europe, the Americas and Asia and a diversified product portfolio for the pharma, cosmetic, and food and beverage industries. The Moulded Glass business unit generated revenues of around EUR 735 million and an adjusted EBITDA margin of around 20% in 2024. The planned divestment is part of Gerresheimer's extensive transformation into a system and solution provider purely for the pharma and biotech industry with a specialized portfolio of primary packaging and drug delivery systems. “We see the best growth opportunities for our newly formed Moulded Glass Powerhouse outside the Gerresheimer Group,” explains Dietmar Siemssen, CEO of Gerresheimer AG. “As part of our strategic transformation, Gerresheimer will focus even stronger on the portfolio of systems and solutions for the pharma and biotech industry.” Global “Moulded Glass Powerhouse” The combined Moulded Glass business of Gerresheimer and Bormioli Pharma comprises eight production plants in Germany, Belgium, Italy, the United States, and India. With around 3,700 employees, the business unit generated pro forma revenues of around EUR 735 million and an adjusted EBITDA margin of around 20% in the financial year 2024. The Moulded Glass Powerhouse provides extensive expertise and global production capabilities for type I, II and III glass products, including decoration and customization. The diversified portfolio includes all kinds of glass packaging for the pharma, cosmetics, and food and beverage industries, such as bottles, containers, jars, and flacons. Gerresheimer continuously invests in state-of-the-art technology for its glass production in all of the Moulded Glass plants. For example, the company has invested around EUR 100 million in an expansion and modernization project at its Moulded Glass site in Lohr am Main, Germany, over the past two years, installing a state-of-the-art, energy-efficient oxy-hybrid furnace. Start of the separation of Moulded Glass As part of the integration of Bormioli Pharma into the Gerresheimer Group, Gerresheimer has begun to establish the combined Moulded Glass business as a global, stand-alone Powerhouse. Today's decision marks the beginning of the separation process. Subsequently the company intends to initiate a sales process. Gerresheimer will provide a further update at its upcoming Capital Markets Day on October 15, 2025. Gerresheimer focusing even stronger on the pharma and biotech industry The planned divestment of the Moulded Glass business is another step in Gerresheimer's transformation into a pure-play system and solution provider for the pharma and biotech industry with an increasing share of specific solutions for biologics and other high-value solutions. By acquiring Bormioli Pharma, Gerresheimer has expanded its portfolio to include additional pharmaceutical primary packaging, closure solutions, accessories, and dosing systems, while also opening up new opportunities for system integration of high-value plastic solutions for the pharma and biotech industry.
Contact Gerresheimer AG
04.08.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
Language: | English |
Company: | Gerresheimer AG |
Peter-Müller-Str. 3 | |
40468 Duesseldorf | |
Germany | |
Phone: | +49-(0)211/61 81-00 |
Fax: | +49-(0)211/61 81-121 |
E-mail: | gerresheimer.ir@gerresheimer.com |
Internet: | http://www.gerresheimer.com |
ISIN: | DE000A0LD6E6 |
WKN: | A0LD6E |
Indices: | MDAX (Aktie) |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
EQS News ID: | 2179242 |
End of News | EQS News Service |
|
2179242 04.08.2025 CET/CEST
Nachrichten zu Gerresheimer AG
Analysen zu Gerresheimer AG
25.09.25 | Gerresheimer Buy | Hauck Aufhäuser Lampe Privatbank AG | |
25.09.25 | Gerresheimer Hold | Deutsche Bank AG | |
24.09.25 | Gerresheimer Halten | DZ BANK | |
24.09.25 | Gerresheimer Overweight | Barclays Capital | |
23.09.25 | Gerresheimer Overweight | JP Morgan Chase & Co. |
Börsentag 2025: Silber vor Verdopplung? Rohstoffexperte über die Chancen
Im Experteninterview erklärt Prof. Dr. Torsten Dennin, welche Faktoren die Preise von Gold, Silber, Kupfer, Uran und Agrarrohstoffen treiben – und welche Chancen & Risiken Anleger jetzt kennen sollten.
👉 Was steckt hinter der aktuellen Gold- und Silber-Rallye?
👉 Welche Rohstoffe gelten 2025 als besonders spannend für Investments?
👉 Wie investieren Anlegerinnen und Anleger am besten in Edelmetalle & Rohstoffe?
Erhalte fundierte Einschätzungen, Marktprognosen und Antworten auf spannende Zuschauerfragen rund um Edelmetalle, Minenaktien, ETFs und Rohstofftrends.
👉🏽 Jetzt auch auf BXplus anmelden und von exklusiven Inhalten rund um Investment & Trading profitieren!
Inside Trading & Investment
Mini-Futures auf SMI
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Investoren schütteln neue Zölle auf Pharmaprodukte ab: SMI geht höher ins Wochenende -- Letztlich Gewinne beim DAX -- US-Börsen zum Handelsende in Grün -- Asiens Börsen schliessen tieferDer heimische Aktienmarkt zeigte sich am Freitag höher. Der deutsche Aktienmarkt verzeichnete ebenfalls Gewinne. Die US-Börsen notierten zum Wochenschluss höher. Die wichtigsten Handelsplätze in Fernost schlossen am Freitag mit Verlusten.
finanzen.net News
Datum | Titel |
---|---|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |